What are effective treatments for urticaria?

Urticaria, commonly known as hives, is a transient, pruritic skin reaction characterized by localized, erythematous, and edematous wheals that typically blanch with pressure. Effective management depends on identifying and avoiding triggers—such as foods (e.g., nuts, shellfish), medications (e.g., NSAIDs, antibiotics), insect stings, infections, or physical stimuli (e.g., cold, heat, pressure)—whenever possible.

First-line pharmacologic treatment consists of second-generation, non-sedating H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine, desloratadine, or levocetirizine). In chronic spontaneous urticaria (CSU), guidelines recommend up-titrating to two to four times the standard dose if symptoms persist, provided safety is confirmed and no contraindications exist. For patients who remain refractory despite high-dose antihistamines, add-on therapy with omalizumab—a humanized monoclonal anti-IgE antibody—is strongly supported by robust clinical evidence and is FDA- and EMA-approved for CSU. Other options in select cases include cyclosporine (with careful monitoring of renal function and blood pressure) or short-term systemic corticosteroids—reserved only for acute, severe flares due to significant adverse effect profiles and lack of long-term efficacy.

Nonpharmacologic strategies are equally important: wearing loose-fitting clothing, avoiding hot showers or vigorous rubbing of the skin, managing stress, and maintaining a symptom diary to help identify potential triggers. Patients with angioedema involving the upper airway—or signs of anaphylaxis such as stridor, wheezing, hypotension, or gastrointestinal distress—require immediate epinephrine administration and urgent emergency evaluation.

A thorough clinical assessment—including detailed history, physical examination, and selective testing (e.g., CBC, thyroid function tests, or autologous serum skin test in chronic cases)—is essential to distinguish spontaneous from inducible urticaria and to rule out underlying systemic disease. Referral to an allergist or dermatologist is recommended for persistent, complex, or treatment-resistant cases.